Hillel Bachrach, MBA

Founder and Managing Partner at 20/20 Healthcare Partners, LLC

Hillel is the Managing Partner of 20/20 HealthCare Partners, LLC, (20/20 HCP), a global investment entity he founded in 2005. 20/20 HCP has invested in many successful companies including Viztek (acquired by Konica Minolta in 2015), Corindus Vascular Robotics (purchased by Siemens HealthCare in 2019), XR Health, SQZ Biotechnology, Verseau Therapeutics and EnClear Therapies. In addition to Variantyx, Hillel currently serves on the Board of Directors for Zixi and Velocamp. Hillel previously served as president of Odin Medical Technologies, Inc., and helped found UltraSPECT, Ltd. which was sold to Pharmalogic in 2019. Hillel received a BS in electrical engineering from Technion Israeli Institute of Technology and an MBA from the Kellogg Graduate School of Management.